MOXCON

MOXCON

Abbreviation for:
Moxonidine Congestive Heart Failure trial

MOXCON

Cardiology A study–Moxonidine Congestive Heart Failure trial–evaluating the efficacy of central sympathetic inhibition on heart failure. See Moxonidine, SIRA.
Mentioned in ?
References in periodicals archive ?
MOXCON was a double-blind, placebo-controlled trial conducted at 425 sites in 17 countries.
An excess of hospitalizations for worsening CHF--a secondary MOXCON end point--was observed in the moxonidine-treated patients.
The MOXCON train wreck effectively ends pursuit of the once promising sympathetic nervous system-dampening approach to CHF therapy.